Cognex Corporation
CGNXTechnologyNASDAQScientific & Technical Instruments
Scan Results
Daily timeframeHeadquartered within the technology sector, Cognex Corporation focuses on Scientific & Technical Instruments services and products. Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks in the United States, Europe, Greater China, and. At a $9.34B market cap, Cognex Corporation ranks as a mid-cap company within technology. Its machine vision products are used to automate the manufacture and distribution of discrete items, such as mobile phones, automotive components, and e-commerce packages, by locating, identifying, inspecting, and measuring them.
Market Cap
$9.34B
Beta
1.48
P/E (TTM)
53.41
P/E (Fwd)
27.48
EPS (TTM)
$1.04
EPS (Fwd)
$2.02
ROE
11.2%
ROA
7.1%
Cash
$404.4M
Total Debt
$72.5M
Free CF
$195.7M
52W Change
15.1%
Annual Financials
Cash vs Debt
Where CGNX stands vs its 150-day and 200-day moving averages
As of the October 19, 2026 close, CGNX finished 10.91% below its 150-day moving average ($60.60) and 5.03% below its 200-day moving average ($56.85). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CGNX overbought or oversold?
At the October 19, 2026 close, CGNX's RSI(14) was 40.5, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Cognex Corporation holds $404.4M in cash against $72.5M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow comes in at $195.7M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 11.2%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 7.1% suggests reasonable efficiency in deploying the company's asset base. Revenue has been relatively flat, moving from $1.01B (2022) to $994.4M (2025).
With cash comfortably exceeding debt, CGNX has financial flexibility that may help navigate uncertain periods. The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing CGNX.